The government must clarify why it is setting up the National Biotechnology Regulatory Authority (NBRA), replacing the existing regulator Genetic Engineering Approval Committee (GEAC) which is already acting as a single window clearance for biotech products. If the government feels that the GEAC is incompetent and inefficient, it should bring it to the public knowledge.